Literature DB >> 1318344

Prevalence of glioblastoma multiforme in subjects with prior therapeutic radiation.

L C Hodges1, J L Smith, A Garrett, S Tate.   

Abstract

This retrospective study profiled subjects with glioblastoma multiforme (GBM) who had previously received therapeutic radiation. A chart review was conducted of 100 adult patients diagnosed with GBM and referred to a major medical center in the southwestern United States. Seventeen patients received previous radiation therapy with an average dose of 48.5 Grey (Gy) and an average latency period of 15 years between initial therapy and GBM diagnosis. Of these 17, four white females fit all four attribution criteria for radiation-induced GBM. Two had been treated with radiation for prolactinomas, one for pinealoma and one for squamous cell cancer of the ethmoid sinus. The addition of these four case studies to the previously published descriptions of 80 cases of gliomas, 36 of which were GBM, subsequent to radiation therapy provides additional support for considering therapeutic radiation as a risk factor for GBM development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318344     DOI: 10.1097/01376517-199204000-00005

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  8 in total

Review 1.  Radiation-induced gliomas: a comprehensive review and meta-analysis.

Authors:  Ryuya Yamanaka; Azusa Hayano; Tomohiko Kanayama
Journal:  Neurosurg Rev       Date:  2016-10-05       Impact factor: 3.042

Review 2.  Environmental risk factors for primary malignant brain tumors: a review.

Authors:  M Wrensch; M L Bondy; J Wiencke; M Yost
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

3.  Discrepant MR spectroscopic and perfusion imaging results in a case of malignant transformation of cerebral glioma.

Authors:  Wen-Chau Wu; Cheng-Yu Chen; Hsiao-Wen Chung; Chun-Jung Juan; Chun-Jen Hsueh; Hong-Wei Gao
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

Review 4.  Epidemiologic and molecular prognostic review of glioblastoma.

Authors:  Jigisha P Thakkar; Therese A Dolecek; Craig Horbinski; Quinn T Ostrom; Donita D Lightner; Jill S Barnholtz-Sloan; John L Villano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

Review 5.  Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review.

Authors:  Ryuya Yamanaka; Eisuke Abe; Toshiteru Sato; Azusa Hayano; Yasuo Takashima
Journal:  Cancers (Basel)       Date:  2017-08-08       Impact factor: 6.639

6.  The future role of personalized medicine in the treatment of glioblastoma multiforme.

Authors:  Jing Li; Chunhui Di; Austin K Mattox; Linda Wu; D Cory Adamson
Journal:  Pharmgenomics Pers Med       Date:  2010-08-19

7.  Modulation of Radiation-Induced Genetic Damage by HCMV in Peripheral Blood Lymphocytes from a Brain Tumor Case-Control Study.

Authors:  Elizabeth A Rourke; Mirtha S Lopez; Claudia M Monroy; Michael E Scheurer; Carol J Etzel; Thomas Albrecht; Melissa L Bondy; Randa A El-Zein
Journal:  Cancers (Basel)       Date:  2010-04-12       Impact factor: 6.639

Review 8.  The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy.

Authors:  Natalia Simionescu; Radu Zonda; Anca Roxana Petrovici; Adriana Georgescu
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.